Join
Live feed
·
PRReleasevia Quantisnow
Cellectis S.A. logo

Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis' Allogeneic CAR-T Platform

ByQuantisnow·Wall Street's wire, on your screen.
CLLS· Cellectis S.A.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLLS (Cellectis S.A.) and more on Quantisnow.